NasdaqCM - Delayed Quote USD
Eyenovia, Inc. (EYEN)
At close: November 7 at 4:00 PM EST
After hours: November 7 at 5:15 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.13 | -0.11 | -0.65 | -0.53 |
| Low Estimate | -0.18 | -0.15 | -0.77 | -0.81 |
| High Estimate | -0.1 | -0.08 | -0.58 | -0.35 |
| Year Ago EPS | -0.18 | -0.18 | -0.66 | -0.65 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | 160k | 1.7M | 1.89M | 9.43M |
| Low Estimate | 30k | 340k | 470k | 4.77M |
| High Estimate | 350k | 3.23M | 3.3M | 13.75M |
| Year Ago Sales | -- | 3k | 4k | 1.89M |
| Sales Growth (year/est) | -- | 56,566.70% | 47,150.00% | 398.90% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.18 | -0.17 | -0.17 | -0.15 |
| EPS Actual | -0.18 | -0.18 | -0.23 | -0.21 |
| Difference | 0 | -0.01 | -0.06 | -0.06 |
| Surprise % | 0.00% | -5.90% | -35.30% | -40.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.13 | -0.11 | -0.65 | -0.53 |
| 7 Days Ago | -0.13 | -0.11 | -0.65 | -0.53 |
| 30 Days Ago | -0.13 | -0.11 | -0.66 | -0.54 |
| 60 Days Ago | -0.13 | -0.11 | -0.66 | -0.55 |
| 90 Days Ago | -0.15 | -0.15 | -0.68 | -0.67 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | EYEN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 27.80% | -- | -- | 5.40% |
| Next Qtr. | 38.90% | -- | -- | 12.70% |
| Current Year | 1.50% | -- | -- | 2.10% |
| Next Year | 18.50% | -- | -- | 12.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.06% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/24/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/16/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2023 |
Related Tickers
ATRA Atara Biotherapeutics, Inc.
10.10
+0.95%
TPST Tempest Therapeutics, Inc.
1.0600
+1.92%
LYRA Lyra Therapeutics, Inc.
0.2650
-5.32%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.9409
+0.85%
ENSC Ensysce Biosciences, Inc.
0.6957
+26.42%
TVGN Tevogen Bio Holdings Inc.
1.1400
-12.31%
MIST Milestone Pharmaceuticals Inc.
1.9500
+8.94%
SLS SELLAS Life Sciences Group, Inc.
1.1600
0.00%
IRD Opus Genetics, Inc.
1.0900
-6.84%
UNCY Unicycive Therapeutics, Inc.
0.5698
+13.51%